Jump to main content
Jump to site search

Issue 6, 2011
Previous Article Next Article

Catalytic, enantioselective synthesis of stilbenecis-diamines: A concise preparation of (−)-Nutlin-3, a potent p53/MDM2 inhibitor

Author affiliations

Abstract

The first highly diastereo- and enantioselective additions of aryl nitromethane pronucleophiles to aryl aldimines are described. Identification of an electron rich chiral Bis(AMidine) catalyst for this aza-Henry variant was key to this development, leading ultimately to differentially protected cis-stilbene diamines in two steps. This method then became the lynchpin for an enantioselective synthesis of (−)-Nutlin-3 (Hoffmann-La Roche), a potent cis-imidazoline small molecule inhibitor of p53-MDM2 used extensively as a probe of cell biology and currently in drug development.

Graphical abstract: Catalytic, enantioselective synthesis of stilbenecis-diamines: A concise preparation of (−)-Nutlin-3, a potent p53/MDM2 inhibitor

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 28 Jan 2011, accepted on 24 Feb 2011 and first published on 25 Mar 2011


Article type: Edge Article
DOI: 10.1039/C1SC00061F
Citation: Chem. Sci., 2011,2, 1076-1079
  •   Request permissions

    Catalytic, enantioselective synthesis of stilbenecis-diamines: A concise preparation of (−)-Nutlin-3, a potent p53/MDM2 inhibitor

    T. A. Davis and J. N. Johnston, Chem. Sci., 2011, 2, 1076
    DOI: 10.1039/C1SC00061F

Search articles by author